4//SEC Filing
Alvarez Jesus 4
Accession 0001209191-18-013683
CIK 0001180262other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:14 PM ET
Size
20.4 KB
Accession
0001209191-18-013683
Insider Transaction Report
Form 4
Alzarez Jesus
VP, General Manager, Mexico
Transactions
- Exercise/Conversion
Common Stock
2018-02-26$79.58/sh+1,929$153,510→ 4,014 total - Award
Stock Appreciation Rights
2018-02-22+873→ 873 totalExercise: $62.51From: 2018-05-09Exp: 2026-05-09→ Common Stock (873 underlying) - Award
Stock Appreciation Rights
2018-02-22+918→ 918 totalExercise: $57.19From: 2018-02-27Exp: 2027-02-27→ Common Stock (918 underlying) - Exercise/Conversion
Stock Appreciation Rights
2018-02-26−1,929→ 0 totalExercise: $79.58From: 2016-06-21Exp: 2023-12-19→ Common Stock (1,929 underlying) - Disposition to Issuer
Common Stock
2018-02-26$86.30/sh−1,779$153,528→ 2,235 total - Tax Payment
Common Stock
2018-02-26$86.30/sh−53$4,574→ 2,182 total - Award
Common Stock
2018-02-26+2,085→ 2,085 total - Award
Stock Appreciation Rights
2018-02-22+5,873→ 5,873 totalExercise: $30.44From: 2018-03-02Exp: 2025-03-02→ Common Stock (5,873 underlying)
Footnotes (5)
- [F1]Consists of restricted stock units ("RSU") under the Herbalife Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Ltd. common stock on vesting. This award will vest 20% each on February 26, 2019 and February 26, 2020, and 60% on February 26, 2021.
- [F2]The reporting person received 97 shares of common stock upon the net exercise of 1,929 stock appreciation rights ("SARS"). The reporting person forfeited 1,779 shares of common stock underlying the SARS in payment of the exercise price and 53 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on February 26, 2018 of $86.30.
- [F3]On March 2, 2015, the reporting person was granted an award of 9,787 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by Herbalife Ltd. (the "Company") of certain performance criteria for each of fiscal 2015, 2016 and 2017. The performance criteria for 2017 was met, resulting in 5,873 SARs which will vest on March 2, 2018.
- [F4]On May 9, 2016, the reporting person was granted an award of 4,366 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2016, 2017 and 2018. The performance criteria for 2017 was met, resulting in 873 SARs which will vest on May 9, 2018.
- [F5]On February 27, 2017, the reporting person was granted an award of 4,590 SARs. The amount and timing of the vesting of these SARs is dependent upon the achievement by the Company of certain performance criteria for each of fiscal 2017, 2018 and 2019. The performance criteria for 2017 was met, resulting in 918 SARs which will vest on February 27, 2018.
Documents
Issuer
HERBALIFE LTD.
CIK 0001180262
Entity typeother
Related Parties
1- filerCIK 0001615466
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 9:14 PM ET
- Size
- 20.4 KB